Talin : a novel inducible antagonist of transforming growth factor-beta 1 (TGF-[beta]1) signal transduction

The survival of breast cancer patients declines when tumors are invasive and have an increased possibility of metastasizing to distal sites. Transforming Growth Factor-beta (TGF-beta) suppresses breast cancer formation by preventing cell cycle progression in mammary epithelial cells. However, at lat...

Full description

Bibliographic Details
Main Author: Rafiei, Shahrzad.
Format: Others
Language:en
Published: McGill University 2007
Subjects:
Online Access:http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=100203
id ndltd-LACETR-oai-collectionscanada.gc.ca-QMM.100203
record_format oai_dc
spelling ndltd-LACETR-oai-collectionscanada.gc.ca-QMM.1002032014-02-13T03:45:24ZTalin : a novel inducible antagonist of transforming growth factor-beta 1 (TGF-[beta]1) signal transductionRafiei, Shahrzad.Talin.Transforming Growth Factor beta1 -- antagonists & inhibitors.The survival of breast cancer patients declines when tumors are invasive and have an increased possibility of metastasizing to distal sites. Transforming Growth Factor-beta (TGF-beta) suppresses breast cancer formation by preventing cell cycle progression in mammary epithelial cells. However, at late stage of mammary carcinogenesis, due to genetic and epigenetic alterations, TGF-beta loses its cytostatic actions, and contributes to tumor invasion by promoting cell proliferation, Actin cytoskeletal reorganization, as well as Epithelial to Mesenchymal Transition (EMT). Despite the key role of TGF-beta1 in tumor suppression as well as tumor progression, the molecular mechanisms underlying the conversion of TGF-beta form an inhibitor of proliferation in mammary breast cancer cells to an inducer of their cell growth and EMT have not been fully elucidated. Thus, acquiring a basic knowledge on the mechanism of TGF-beta regulating its target genes and its contribution to cancer progression may highlight new avenues for cancer therapy development. This prompted us to further investigate and identify TGF-beta-inducible genes that may be involved in TGF-beta biological responses during tumorigenesis.In this thesis, we identified Talin as a novel TGF-beta1 target gene that acts as an antagonist to inhibit TGF-beta-mediated cell growth arrest and transcriptional activity in mammary cancer cell line, MCF-7. Searching for new partners of activated Smads, we found that TGF-beta1 induces Talin translocation from cytosol to the plasma membrane where Talin physically interacts with the TGF-beta1 signaling components, the Smads and the receptors. Furthermore, we observed that TGF-beta1 stimulation leads to the formation of Actin stress fibers where Talin was detected at the end of these stress fibers. Taken all together, the obtained data show that TGF-beta1 positively induced expression of Talin and suggests a role for Talin, which acts as a negative feedback loop to control TGF-beta biological responses.McGill University2007Electronic Thesis or Dissertationapplication/pdfenalephsysno: 002652770proquestno: AAIMR38428Theses scanned by UMI/ProQuest.© Shahrzad Rafiei, 2007Master of Science (Division of Experimental Medicine.) http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=100203
collection NDLTD
language en
format Others
sources NDLTD
topic Talin.
Transforming Growth Factor beta1 -- antagonists & inhibitors.
spellingShingle Talin.
Transforming Growth Factor beta1 -- antagonists & inhibitors.
Rafiei, Shahrzad.
Talin : a novel inducible antagonist of transforming growth factor-beta 1 (TGF-[beta]1) signal transduction
description The survival of breast cancer patients declines when tumors are invasive and have an increased possibility of metastasizing to distal sites. Transforming Growth Factor-beta (TGF-beta) suppresses breast cancer formation by preventing cell cycle progression in mammary epithelial cells. However, at late stage of mammary carcinogenesis, due to genetic and epigenetic alterations, TGF-beta loses its cytostatic actions, and contributes to tumor invasion by promoting cell proliferation, Actin cytoskeletal reorganization, as well as Epithelial to Mesenchymal Transition (EMT). Despite the key role of TGF-beta1 in tumor suppression as well as tumor progression, the molecular mechanisms underlying the conversion of TGF-beta form an inhibitor of proliferation in mammary breast cancer cells to an inducer of their cell growth and EMT have not been fully elucidated. Thus, acquiring a basic knowledge on the mechanism of TGF-beta regulating its target genes and its contribution to cancer progression may highlight new avenues for cancer therapy development. This prompted us to further investigate and identify TGF-beta-inducible genes that may be involved in TGF-beta biological responses during tumorigenesis. === In this thesis, we identified Talin as a novel TGF-beta1 target gene that acts as an antagonist to inhibit TGF-beta-mediated cell growth arrest and transcriptional activity in mammary cancer cell line, MCF-7. Searching for new partners of activated Smads, we found that TGF-beta1 induces Talin translocation from cytosol to the plasma membrane where Talin physically interacts with the TGF-beta1 signaling components, the Smads and the receptors. Furthermore, we observed that TGF-beta1 stimulation leads to the formation of Actin stress fibers where Talin was detected at the end of these stress fibers. Taken all together, the obtained data show that TGF-beta1 positively induced expression of Talin and suggests a role for Talin, which acts as a negative feedback loop to control TGF-beta biological responses.
author Rafiei, Shahrzad.
author_facet Rafiei, Shahrzad.
author_sort Rafiei, Shahrzad.
title Talin : a novel inducible antagonist of transforming growth factor-beta 1 (TGF-[beta]1) signal transduction
title_short Talin : a novel inducible antagonist of transforming growth factor-beta 1 (TGF-[beta]1) signal transduction
title_full Talin : a novel inducible antagonist of transforming growth factor-beta 1 (TGF-[beta]1) signal transduction
title_fullStr Talin : a novel inducible antagonist of transforming growth factor-beta 1 (TGF-[beta]1) signal transduction
title_full_unstemmed Talin : a novel inducible antagonist of transforming growth factor-beta 1 (TGF-[beta]1) signal transduction
title_sort talin : a novel inducible antagonist of transforming growth factor-beta 1 (tgf-[beta]1) signal transduction
publisher McGill University
publishDate 2007
url http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=100203
work_keys_str_mv AT rafieishahrzad talinanovelinducibleantagonistoftransforminggrowthfactorbeta1tgfbeta1signaltransduction
_version_ 1716638254969651200